Confronting the Fungus Among Us in the Airways of People with Cystic Fibrosis

Overview

Journal Ann Am Thorac Soc

Date 2025 Jan 31

PMID 39887694

Authors

Jessica Clarion

Jonathan D Cogen

Affiliations

Soon will be listed here.

References

Morgan S, Nichols D, Ni W, Hong G, Salipante S, Solomon G . Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces in Cystic Fibrosis. Am J Respir Crit Care Med. 2024; 210(9):1155-1158. DOI: 10.1164/rccm.202406-1128RL. View

ODea A, Feng R, Glaser L, Kubrak C, Rubenstein R, Dorgan D . The Clinical Association between and Respiratory Outcomes in Adolescents and Adults with Cystic Fibrosis. Ann Am Thorac Soc. 2023; 20(7):984-992. DOI: 10.1513/AnnalsATS.202210-852OC. View

Magee L, Louis M, Khan V, Micalo L, Chaudary N . Managing Fungal Infections in Cystic Fibrosis Patients: Challenges in Clinical Practice. Infect Drug Resist. 2021; 14:1141-1153. PMC: 7998013. DOI: 10.2147/IDR.S267219. View

Kraemer R, Delosea N, Ballinari P, Gallati S, Crameri R . Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med. 2006; 174(11):1211-20. DOI: 10.1164/rccm.200603-423OC. View

Hong G, Alby K, Ng S, Fleck V, Kubrak C, Rubenstein R . The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis. J Cyst Fibros. 2019; 19(1):125-130. PMC: 7839066. DOI: 10.1016/j.jcf.2019.08.008. View

Gibson R, Burns J, Ramsey B . Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003; 168(8):918-51. DOI: 10.1164/rccm.200304-505SO. View

Oermann C, Retsch-Bogart G, Quittner A, Gibson R, McCoy K, Montgomery A . An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis. Pediatr Pulmonol. 2010; 45(11):1121-34. PMC: 3867945. DOI: 10.1002/ppul.21301. View

Tracy M, Moss R . The myriad challenges of respiratory fungal infection in cystic fibrosis. Pediatr Pulmonol. 2018; 53(S3):S75-S85. DOI: 10.1002/ppul.24126. View

Cogen J, Kahl B, Maples H, McColley S, Roberts J, Winthrop K . Finding the relevance of antimicrobial stewardship for cystic fibrosis. J Cyst Fibros. 2020; 19(4):511-520. DOI: 10.1016/j.jcf.2020.02.012. View

10.

Agarwal R, Muthu V, Sehgal I, Dhooria S, Prasad K, Aggarwal A . Allergic Bronchopulmonary Aspergillosis. Clin Chest Med. 2022; 43(1):99-125. DOI: 10.1016/j.ccm.2021.12.002. View

11.

Faerber J, Kawut S, Hadjiliadis D, Hong G . The Real-World Effectiveness of Antifungals in People with Cystic Fibrosis and -Positive Cultures. Ann Am Thorac Soc. 2024; 22(2):193-199. PMC: 11808554. DOI: 10.1513/AnnalsATS.202312-1070OC. View